Supportive Care

Molly Williams, DNP, AGACNP-BC, ACHPN, discusses gaps in oncology through a palliative care lens, focusing on symptom burden, fatigue, and essential support for caregivers.

Natalia Neparidze, MD, discusses subcutaneous daratumumab safety, MRD as a clinical endpoint, and emerging therapies for multiple myeloma management.

Research presented at the APOS Conference demonstrated negative beliefs in parents and caregivers of pediatric patients with cancer.

A physician, physician assistant, and nurse practitioner share perspectives on integrative medicine in oncology.

Amber Altidor, NP, shares how oncology nurses can use teach-back methods and learning style assessments to improve patient education on medication toxicities.

Data presented at the annual APOS Conference revealed training and workflow issues in providing developmentally appropriate cancer care to AYA patients.

Data presented at the APOS Annual Conference highlighted sexual function issues and a web-based intervention for AYA cancer survivors.

Patients younger than 40 experience higher rates of CINV and more commonly use marijuana, diet changes, and other methods to manage symptoms.

Radiation-induced heart damage in breast cancer is a growing clinical concern, yet biomarkers and preventive therapies remain lacking.

Mark S. Lin, MSN, FNP-BC, highlighted nursing considerations for breast reconstruction surgery in breast cancer.

Lillian Rodich, PA-C, MPH, stressed that nurses can take advantage of accessible and local integrative medicine resources to treat patients with cancer.

Don S. Dizon, MD, FACP, FASCO, shared insights on what pregnancy looks like with a breast cancer diagnosis and what those considering pregnancy should know.

Samantha Shenoy, NP, MSN, provides nursing guidance on teclistamab/subcutaneous daratumumab’s second-line approval in multiple myeloma.

What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast cancer?

A real-world study found rates of toxicity-related T-DXd discontinuation in HER2-low metastatic breast cancer similar to those observed in DESTINY-Breast04.

Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger age groups with mccRCC.

Explore safety and efficacy findings from KEYNOTE-B15/EV-304, LITESPARK-011, and more from the ASCO Genitourinary Cancers Symposium.

With the addition of pembrolizumab to standard androgen deprivation therapy and radiation, immune-related adverse events are more likely.

ONS is developing a collection of photos of dermatologic toxicities across skin types to address disparities in the care of patients of color with cancer.

Claire Conley, PhD, and Marcelo Sleiman, Jr., discuss the need for protocols in supporting patients’ psychosocial needs.

David C. Leopold, MD, explains how evidence-based integrative therapies like acupuncture and nutrition improve oncology patient outcomes and compliance.

Practical examples of advanced practice provider–led initiatives that improve safety, symptom management, and patient outcomes.

Kelly Grosklags, LICSW, BCD, FAAGC, FT, shares advice for dealing with grief in oncology nursing, from treating patients in denial to showing emotion in front of them.

Kelly Grosklags, LICSW, BCD, FAAGC, FT, shares insights for dealing with grief as an oncology clinician.

A 5-day NYC nurses' strike raises concerns about staffing, patient safety, and the critical role of oncology nurses in cancer care.

Margarita Huober, AGNP, AOCNP, explains that understanding a patient on an individual level leads to more informed care decisions in RCC.

Transportation is a key accessibility issue for patients with HR-positive metastatic breast cancer receiving CDK4/6 inhibitors at community clinics.

ECOG performance status of 1 was linked with worse patient-reported outcomes in patients with gastric or gastroesophageal junction adenocarcinoma.